• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

关于银及含较轻四价烯的双银配合物的密度泛函理论研究:银和双银卡宾是否是抑制SARS-CoV-2的候选物?来自分子对接模拟的见解。

A density functional theory study on silver and bis-silver complexes with lighter tetrylene: are silver and bis-silver carbenes candidates for SARS-CoV-2 inhibition? Insight from molecular docking simulation.

作者信息

Bui Thanh Q, Phuong Loan Huynh Thi, Ai My Tran Thi, Quang Duong Tuan, Phuong Thuy Bui Thi, Nhan Vo Duy, Quy Phan Tu, Van Tat Pham, Dao Duy Quang, Trung Nguyen Tien, Huynh Lam K, Ai Nhung Nguyen Thi

机构信息

Department of Chemistry, University of Sciences, Hue University Hue City 530000 Vietnam

Department of Chemistry, University of Education, Hue University Hue City 530000 Vietnam.

出版信息

RSC Adv. 2020 Aug 21;10(51):30961-30974. doi: 10.1039/d0ra05159d. eCollection 2020 Aug 17.

DOI:10.1039/d0ra05159d
PMID:35516033
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9056359/
Abstract

Ribavirin and remdesivir have been preclinically reported as potential drugs for the treatment of SARS-CoV-2 infection, while light silver tetrylene complexes (NHE-AgCl and (NHE-AgCl) with E = C, Si, and Ge) have gained significant interest due to their promising applicability on the cytological scale. Firstly, the structures and bonding states of silver-tetrylene complexes (NHE-Ag) and bis-silver-tetrylene complexes (NHE-Ag-bis) were investigated using density functional theory (DFT) at the BP86 level with the def2-SVP and def2-TZVPP basis sets. Secondly, the inhibitory capabilities of the carbene complexes (NHC-Ag and NHC-Ag-bis) and the two potential drugs (ribavirin and remdesivir) on human-protein ACE2 and SARS-CoV-2 protease PDB6LU7 were evaluated using molecular docking simulation. The carbene ligand NHC bonds in a head-on configuration with AgCl and (AgCl), whereas, the other NHE (E = Si and Ge) tetrylene ligands bond in a side-on mode to the metal fragments. The bond dissociation energy (BDE) of the NHE-Ag bond in the complex families follows the order of NHC-Ag > NHSi-Ag > NHGe-Ag and NHSi-Ag-bis > NHGe-Ag-bis > NHC-Ag-bis. The natural bond orbital analysis implies that the [NHE→AgCl] and [(NHE)→(AgCl)] donations are derived mainly from the σ- and π-contributions of the ligands. The docking results indicate that both the ACE2 and PDB6LU7 proteins are strongly inhibited by silver-carbene NHC-Ag, bis-silver-carbene NHC-Ag-bis, ribavirin, and remdesivir with the docking score energy values varying from -17.5 to -16.5 kcal mol and -16.9 to -16.6 kcal mol, respectively. The root-mean-square deviation values were recorded to be less than 2 Å in all the calculated systems. Thus, the present study suggests that silver-carbene NHC-Ag and bis-silver-carbene NHC-Ag-bis complexes are potential candidates to inhibit ACE2 and PDB6LU7, and thus potentially conducive to prevent infection caused by the SARS-CoV-2 virus.

摘要

利巴韦林和瑞德西韦在临床前研究中已被报道为治疗新型冠状病毒肺炎(SARS-CoV-2)感染的潜在药物,而轻量的特屈伦银配合物(NHE-AgCl和(NHE-AgCl),其中E = C、Si和Ge)因其在细胞学尺度上具有广阔的应用前景而备受关注。首先,采用密度泛函理论(DFT)在BP86水平下,使用def2-SVP和def2-TZVPP基组研究了特屈伦银配合物(NHE-Ag)和双特屈伦银配合物(NHE-Ag-bis)的结构和键合状态。其次,利用分子对接模拟评估了卡宾配合物(NHC-Ag和NHC-Ag-bis)以及两种潜在药物(利巴韦林和瑞德西韦)对人类蛋白血管紧张素转换酶2(ACE2)和新型冠状病毒肺炎蛋白酶PDB6LU7的抑制能力。卡宾配体NHC以头对头构型与AgCl和(AgCl)键合,而其他NHE(E = Si和Ge)特屈伦配体以侧对侧模式与金属片段键合。配合物家族中NHE-Ag键的键解离能(BDE)顺序为NHC-Ag > NHSi-Ag > NHGe-Ag以及NHSi-Ag-bis > NHGe-Ag-bis > NHC-Ag-bis。自然键轨道分析表明,[NHE→AgCl]和[(NHE)→(AgCl)]的电子给予主要源于配体的σ和π贡献。对接结果表明,卡宾银NHC-Ag、双卡宾银NHC-Ag-bis、利巴韦林和瑞德西韦均对ACE2和PDB6LU7蛋白有强烈抑制作用,对接分数能量值分别在-17.5至-16.5 kcal/mol和-16.9至-16.6 kcal/mol之间。在所有计算体系中,均记录到均方根偏差值小于2 Å。因此,本研究表明卡宾银NHC-Ag和双卡宾银NHC-Ag-bis配合物是抑制ACE2和PDB6LU7的潜在候选物,因此可能有助于预防新型冠状病毒肺炎病毒引起的感染。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af3d/9056359/b9a26f2a09ba/d0ra05159d-f10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af3d/9056359/979d685ca8d6/d0ra05159d-s1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af3d/9056359/90dc154fe5bb/d0ra05159d-s2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af3d/9056359/6c5937d9d9c2/d0ra05159d-s3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af3d/9056359/89c1783aecbd/d0ra05159d-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af3d/9056359/410dd98d73ad/d0ra05159d-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af3d/9056359/5b972e06a69a/d0ra05159d-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af3d/9056359/2053a23e3aff/d0ra05159d-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af3d/9056359/15ba802d11c2/d0ra05159d-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af3d/9056359/def346a48789/d0ra05159d-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af3d/9056359/fcfa74cc9dfa/d0ra05159d-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af3d/9056359/226995f25a79/d0ra05159d-f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af3d/9056359/6aaadc6c81de/d0ra05159d-f9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af3d/9056359/b9a26f2a09ba/d0ra05159d-f10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af3d/9056359/979d685ca8d6/d0ra05159d-s1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af3d/9056359/90dc154fe5bb/d0ra05159d-s2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af3d/9056359/6c5937d9d9c2/d0ra05159d-s3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af3d/9056359/89c1783aecbd/d0ra05159d-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af3d/9056359/410dd98d73ad/d0ra05159d-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af3d/9056359/5b972e06a69a/d0ra05159d-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af3d/9056359/2053a23e3aff/d0ra05159d-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af3d/9056359/15ba802d11c2/d0ra05159d-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af3d/9056359/def346a48789/d0ra05159d-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af3d/9056359/fcfa74cc9dfa/d0ra05159d-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af3d/9056359/226995f25a79/d0ra05159d-f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af3d/9056359/6aaadc6c81de/d0ra05159d-f9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af3d/9056359/b9a26f2a09ba/d0ra05159d-f10.jpg

相似文献

1
A density functional theory study on silver and bis-silver complexes with lighter tetrylene: are silver and bis-silver carbenes candidates for SARS-CoV-2 inhibition? Insight from molecular docking simulation.关于银及含较轻四价烯的双银配合物的密度泛函理论研究:银和双银卡宾是否是抑制SARS-CoV-2的候选物?来自分子对接模拟的见解。
RSC Adv. 2020 Aug 21;10(51):30961-30974. doi: 10.1039/d0ra05159d. eCollection 2020 Aug 17.
2
Transition-metal complexes of tetrylones [(CO)5W-E(PPh3)2] and tetrylenes [(CO)5W-NHE] (E=C-Pb): a theoretical study.偕二唑啉 [(CO)5W-E(PPh3)2] 和偕二氮烯 [(CO)5W-NHE] (E=C-Pb) 的过渡金属配合物:理论研究。
Chemistry. 2012 Oct 1;18(40):12733-48. doi: 10.1002/chem.201200741. Epub 2012 Sep 3.
3
Metallosupramolecular Architectures Obtained from Poly-N-heterocyclic Carbene Ligands.基于多氮杂环卡宾配体的金属超分子结构。
Acc Chem Res. 2017 Sep 19;50(9):2167-2184. doi: 10.1021/acs.accounts.7b00158. Epub 2017 Aug 25.
4
N-Heterocyclic Silylenes as Ligands in Transition Metal Carbonyl Chemistry: Nature of Their Bonding and Supposed Innocence.N-杂环硅烯在过渡金属羰基化学中作为配体:其成键本质及假定的惰性
Chemistry. 2020 Sep 1;26(49):11276-11292. doi: 10.1002/chem.202001062. Epub 2020 Jul 27.
5
Synthesis, characterization, and structure-activity relationship of the antimicrobial activities of dinuclear N-heterocyclic carbene (NHC)-silver(I) complexes.双核N-杂环卡宾(NHC)-银(I)配合物的合成、表征及其抗菌活性的构效关系
J Inorg Biochem. 2016 Oct;163:110-117. doi: 10.1016/j.jinorgbio.2016.06.031. Epub 2016 Jun 29.
6
Silver(I) complexes of mono- and bidentate N-heterocyclic carbene ligands: synthesis, crystal structures, and in vitro antibacterial and anticancer studies.单核和双齿 N-杂环卡宾配体的银(I)配合物:合成、晶体结构以及体外抗菌和抗癌研究。
Eur J Med Chem. 2015 Jan 27;90:82-92. doi: 10.1016/j.ejmech.2014.11.005. Epub 2014 Nov 4.
7
Borylene complexes (BH)L2 and nitrogen cation complexes (N+)L2: isoelectronic homologues of carbones CL2.硼烷配合物 (BH)L2 和氮阳离子配合物 (N+)L2:与碳烯 CL2 互为等电子体。
Chemistry. 2012 Apr 27;18(18):5676-92. doi: 10.1002/chem.201103965. Epub 2012 Mar 20.
8
Different Donor-Acceptor Interactions of Carbene Ligands in Heteroleptic Divalent Group 14 Compounds, LEL' (E=C-Sn; L=N-Heterocyclic Carbene; L'=Cyclic Alkyl(Amino) Carbene).杂配二价第14族化合物LEL'(E = C - Sn;L = N - 杂环卡宾;L' = 环状烷基(氨基)卡宾)中卡宾配体的不同供体 - 受体相互作用
Chemistry. 2018 Mar 12;24(15):3816-3824. doi: 10.1002/chem.201705719. Epub 2018 Feb 16.
9
Ruthenium(II) complexes of N-heterocyclic carbenes derived from imidazolium-linked cyclophanes.源自咪唑连接环番的 N-杂环卡宾的钌(II)配合物。
Dalton Trans. 2014 Oct 21;43(39):14710-9. doi: 10.1039/c4dt01473a.
10
Stabilization of group 14 elements E = C, Si, Ge by hetero-bileptic ligands cAAC, MCO with push-pull mechanism.通过具有推拉机制的杂双齿配体cAAC、MCO对第14族元素E = C、Si、Ge进行稳定化。
J Comput Chem. 2021 Jun 15;42(16):1159-1177. doi: 10.1002/jcc.26530. Epub 2021 Apr 15.

引用本文的文献

1
Polypropylene Modified with Ag-Based Semiconductors as a Potential Material against SARS-CoV-2 and Other Pathogens.用银基半导体改性的聚丙烯作为对抗新型冠状病毒和其他病原体的潜在材料
ACS Appl Polym Mater. 2022 Sep 16;4(10):7102-7114. doi: 10.1021/acsapm.2c00744. eCollection 2022 Oct 14.
2
Methodology-Centered Review of Molecular Modeling, Simulation, and Prediction of SARS-CoV-2.基于方法的 SARS-CoV-2 分子建模、模拟和预测综述。
Chem Rev. 2022 Jul 13;122(13):11287-11368. doi: 10.1021/acs.chemrev.1c00965. Epub 2022 May 20.
3
Applications of density functional theory in COVID-19 drug modeling.

本文引用的文献

1
Computational screening of antagonists against the SARS-CoV-2 (COVID-19) coronavirus by molecular docking.基于分子对接的 SARS-CoV-2(COVID-19)冠状病毒拮抗剂的计算筛选。
Int J Antimicrob Agents. 2020 Aug;56(2):106012. doi: 10.1016/j.ijantimicag.2020.106012. Epub 2020 May 8.
2
Novel coronavirus treatment with ribavirin: Groundwork for an evaluation concerning COVID-19.利巴韦林治疗新型冠状病毒:COVID-19 评估的基础。
J Med Virol. 2020 Jul;92(7):740-746. doi: 10.1002/jmv.25798. Epub 2020 Apr 10.
3
Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro.
密度泛函理论在 COVID-19 药物建模中的应用。
Drug Discov Today. 2022 May;27(5):1411-1419. doi: 10.1016/j.drudis.2021.12.017. Epub 2021 Dec 23.
4
On the Inhibitability of Natural Products Isolated from towards Tyrosine Phosphatase 1B (PTP1B) and α-Glucosidase (3W37): An In Vitro and In Silico Study.从天然产物中分离得到的对酪氨酸磷酸酶 1B(PTP1B)和α-葡萄糖苷酶(3W37)的抑制作用的不可抑制性:体外和计算研究。
Molecules. 2021 Jun 17;26(12):3691. doi: 10.3390/molecules26123691.
瑞德西韦和氯喹在体外能有效抑制新出现的新型冠状病毒(2019 - 新冠病毒)。
Cell Res. 2020 Mar;30(3):269-271. doi: 10.1038/s41422-020-0282-0. Epub 2020 Feb 4.
4
Molecular Docking Studies of HIV-1 Resistance to Reverse Transcriptase Inhibitors: Mini-Review.HIV-1 逆转录酶抑制剂耐药性的分子对接研究:综述
Molecules. 2018 May 21;23(5):1233. doi: 10.3390/molecules23051233.
5
Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease.冠状病毒对抗病毒药物瑞德西韦(GS-5734)的易感性是由病毒聚合酶和校对核糖核酸外切酶介导的。
mBio. 2018 Mar 6;9(2):e00221-18. doi: 10.1128/mBio.00221-18.
6
Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses.广谱抗病毒药物GS-5734可抑制流行性冠状病毒和人畜共患冠状病毒。
Sci Transl Med. 2017 Jun 28;9(396). doi: 10.1126/scitranslmed.aal3653.
7
GS-5734 and its parent nucleoside analog inhibit Filo-, Pneumo-, and Paramyxoviruses.GS-5734 及其母体核苷类似物可抑制副粘病毒、流感病毒和副流感病毒。
Sci Rep. 2017 Mar 6;7:43395. doi: 10.1038/srep43395.
8
Computational predictive models for P-glycoprotein inhibition of in-house chalcone derivatives and drug-bank compounds.用于预测内部查耳酮衍生物和药物库化合物对P-糖蛋白抑制作用的计算模型
Mol Divers. 2016 Nov;20(4):945-961. doi: 10.1007/s11030-016-9688-5. Epub 2016 Jul 18.
9
Coronaviruses - drug discovery and therapeutic options.冠状病毒——药物研发与治疗选择
Nat Rev Drug Discov. 2016 May;15(5):327-47. doi: 10.1038/nrd.2015.37. Epub 2016 Feb 12.
10
Cooperative Lewis acid/-heterocyclic carbene catalysis.协同路易斯酸/杂环卡宾催化
Chem Sci. 2012 Jan 1;3(1):53-57. doi: 10.1039/C1SC00621E.